EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer

NCT01485848 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer Recurrent

Interventions

DRUG: EP-100
DRUG: Paclitaxel

Sponsor

Esperance Pharmaceuticals Inc